Related content

Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients

By Zhong L.   Peng X.   Hidalgo G.E.   Doherty D.E.   Stromberg A.J.   Hirschowitz E.A.  

Cancer Detection and Prevention, Vol. 27, Iss. 4, 2003-01 ,pp. : 285-290

Elsevier

Access to resources Recommend Favorite

Serum semicarbazide-sensitive amine oxidase (SSAO) activity correlates with VEGF in non-small-cell lung cancer patients

By Garpenstrand Håkan   Bergqvist Michael   Brattström Daniel   Larsson Anders   Oreland Lars   Hesselius Patrik   Wagenius Gunnar  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 241-250

Humana Press, Inc

Access to resources Recommend Favorite

Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study

By Frasci Giuseppe   Comella Pasquale   Thomas Renato   Bonito Maurizio   Lapenta Liliana   Capasso Immacolata   Botti Gerardo   Vallone Paolo   Rosa Vincenzo   D'Aiuto Giuseppe   Comella Giuseppe  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 1, 2004-01 ,pp. : 25-32

Springer Publishing Company

Access to resources Recommend Favorite

Interstitial lung disease in patients with small cell lung cancer

By Miyazaki Kunihiko   Satoh Hiroaki   Kurishima Koichi   Nakamura Ryota   Ishikawa Hiroichi   Kagohashi Katsunori   Hizawa Nobuyuki  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 763-767

Humana Press, Inc

Access to resources Recommend Favorite

Effects of Gemcitabine on renal function in patients with non-small cell lung cancer

By Gietema J.A.   Groen H.J.M.   Meijer S.   Smit E.F.  

European Journal of Cancer, Vol. 34, Iss. 1, 1998-01 ,pp. : 199-202

Elsevier

Access to resources Recommend Favorite